“Sickle Cell Disease Pipeline Insight, 2021” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Sickle cell disease pipeline landscape.
The assessment part of the report embraces in-depth Sickle Cell Disease commercial assessment and clinical assessment of the Sickle Cell Disease pipeline products from the pre-clinical developmental phase to the marketed phase.
In the report, a detailed description of the drug is proffered including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Sickle Cell Disease collaborations, licensing, mergers and acquisition, funding, designations, and other product-related details.
Sickle Cell Disease market size is expected to increase during the forecast period owing to the launch of upcoming therapies.
Sickle Cell Disease Companies:
• CSL Behring
• Magenta Therapeutics
• Molecules for Health
• Hillhurst Biopharmaceuticals
• ORYZON therapeutics
• Regenacy Pharmaceuticals
• Dystrogen Therapeutics
• ReveraGen
• Editas Medicine
• Bioverativ ( A Sanofi company)
• Genethon
• Syros Therapeutics
• Gilead Sciences
• Bluebird bio
• CRISPR Therapeutics
• Novo Nordisk
• Forma Therapeutics
• La Jolla
• Merganser Biotech
• NuvOx Pharma
• Pfizer
• Sanofi
• LEO Pharma
• Invenux
• Micelle BioPharma
• AstraZeneca
• Merck Sharp & Dohme
• Angiocrine Bioscience
• Beam Therapeutics
• Fulcrum Therapeutics
• Nicox
• Shire
• TauTona Group
• EpiDestiny
• RadioRx
• Bellicum Pharmaceuticals
• Novartis
• Miltenyi Biotec
• Nova Laboratories
• Gamida-Cell
• Addmedica Sasa
• Bristol Myers Squibb
• Imara
• Ironwood
• ARUVANT (Roivant’s Vant)
• Prolong Pharmaceuticals
• Modus Therapeutics
Request for free sample report: https://www.delveinsight.com/sample-request/sickle-cell-disease-pipeline-insight
Sickle Cell Disease Therapies Covered in the Report Include:
Sickle Cell Disease Pipeline Analysis
The report provides insights into:
The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university web sites and industry-specific third-party sources, etc.
Scope of the report
Report Highlights
Table of Content
About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/sickle-cell-disease-pipeline-insight